The Ubiquitin Proteasome System in ER Quality Control

ER 质量控制中的泛素蛋白酶体系统

基本信息

  • 批准号:
    8462992
  • 负责人:
  • 金额:
    $ 53.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this project is to elucidate the mechanisms by which proteins in the secretory pathway are recognized and destroyed by the ubiquitin-proteasome system (UPS) in a process known as endoplasmic reticulum-associated degradation (ERAD). Substrates committed to this fate are diverse, and include secreted and integral membrane proteins that are unable to fold correctly as a consequence of mutation or inefficient assembly into oligomeric complexes. During the current funding period we have made exceptional progress in achieving our primary aims of establishing a robust and versatile functional genomics platform to map functional substrate-specific sub-networks within the mammalian ERAD system, and have exceeded these aims in developing powerful proteomic tools that have enabled us to compile a preliminary map of the mammalian ERAD interactome. The present application proposes to expand these achievements with the goal of defining the role of chaperones and glycans in luminal ER quality control surveillance and to develop a comprehensive understanding of the composition and functional organization of the ERAD system in mammals. These goals are defined three specific aims. The first specific aim will employ established biochemical, cell biological and biophysical methodology to define the mechanisms by which substrates are committed to ERAD pathway and the role of the molecular chaperone, GRP94, in this process. The second specific aim will conduct a large-scale comprehensive functional genomic screen of the entire UPS in the degradation of a set of topologically diverse ERAD substrates and will validate these components using a battery of informatic and biochemical tools. The third specific aim is to construct a comprehensive map of the mammalian ERAD network by combining in-depth mining of the ERAD proteome with gene silencing to identify network topology, and to overlay this map on the substrate-specific functional network generated in Aim 2. These studies are focused on elucidating the molecular mechanisms by which folding or assembly-defective proteins are destroyed by mammalian cells, and therefore, have direct bearing on human health.
描述(由申请人提供):本项目的长期目标是阐明分泌途径中的蛋白质在被称为内质网相关降解(ERAD)的过程中被泛素-蛋白酶体系统(UPS)识别和破坏的机制。致力于这种命运的底物是多样的,并且包括由于突变或低效组装成寡聚复合物而不能正确折叠的分泌的和整合的膜蛋白。在目前的资助期间,我们在实现我们的主要目标,建立一个强大的和多功能的功能基因组学平台,映射功能底物特定的子网络在哺乳动物ERAD系统中取得了非凡的进展,并已超过这些目标,在开发强大的蛋白质组学工具,使我们能够编译的哺乳动物ERAD相互作用组的初步地图。本申请提出扩展这些成就,目标是定义伴侣蛋白和聚糖在管腔ER质量控制监测中的作用,并发展对哺乳动物中ERAD系统的组成和功能组织的全面理解。这些目标被定义为三个具体目标。第一个具体目标将采用已建立的生物化学,细胞生物学和生物物理学方法来定义底物被提交给ERAD途径的机制和分子伴侣GRP 94在该过程中的作用。第二个具体目标将进行大规模的全面功能基因组筛选的整个UPS在一组拓扑结构不同的ERAD基板的降解,并将验证这些组件使用电池的信息和生化工具。第三个具体的目标是构建一个全面的地图哺乳动物ERAD网络相结合的ERAD蛋白质组的深入挖掘与基因沉默,以确定网络拓扑结构,并覆盖这一地图上的目标2中产生的底物特异性功能网络。这些研究的重点是阐明折叠或组装缺陷蛋白质被哺乳动物细胞破坏的分子机制,因此对人类健康有直接影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RON R KOPITO其他文献

RON R KOPITO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RON R KOPITO', 18)}}的其他基金

The role of UFMylation in ribosome quality control at the ER
UFMylation 在 ER 核糖体质量控制中的作用
  • 批准号:
    10561470
  • 财政年份:
    2023
  • 资助金额:
    $ 53.95万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8686087
  • 财政年份:
    2012
  • 资助金额:
    $ 53.95万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    9098811
  • 财政年份:
    2012
  • 资助金额:
    $ 53.95万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8401724
  • 财政年份:
    2012
  • 资助金额:
    $ 53.95万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8490454
  • 财政年份:
    2012
  • 资助金额:
    $ 53.95万
  • 项目类别:
The ubiquitin proteasome system in ER quality control
内质网质量控制中的泛素蛋白酶体系统
  • 批准号:
    9912161
  • 财政年份:
    2006
  • 资助金额:
    $ 53.95万
  • 项目类别:
The Ubiquitin Proteasome System in ER Quality Control
ER 质量控制中的泛素蛋白酶体系统
  • 批准号:
    8260579
  • 财政年份:
    2006
  • 资助金额:
    $ 53.95万
  • 项目类别:
The ubiquitin proteasome system in ER quality control
内质网质量控制中的泛素蛋白酶体系统
  • 批准号:
    10193992
  • 财政年份:
    2006
  • 资助金额:
    $ 53.95万
  • 项目类别:
The Ubiquitin Proteasome System in Quality Control
泛素蛋白酶体系统在质量控制中的应用
  • 批准号:
    7616236
  • 财政年份:
    2006
  • 资助金额:
    $ 53.95万
  • 项目类别:
The Ubiquitin Proteasome System in ER Quality Control
ER 质量控制中的泛素蛋白酶体系统
  • 批准号:
    7887688
  • 财政年份:
    2006
  • 资助金额:
    $ 53.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了